These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3139380)

  • 1. Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease.
    Lieberman BY; Fiocchi C; Youngman KR; Sapatnekar WK; Proffitt MR
    Dig Dis Sci; 1988 Oct; 33(10):1297-304. PubMed ID: 3139380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma.
    Qin OY; el-Youssef M; Yen-Lieberman B; Sapatnekar W; Youngman KR; Kusugami K; Fiocchi C
    Dig Dis Sci; 1988 Dec; 33(12):1528-36. PubMed ID: 3143537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease.
    Kusugami K; Matsuura T; West GA; Youngman KR; Rachmilewitz D; Fiocchi C
    Gastroenterology; 1991 Dec; 101(6):1594-605. PubMed ID: 1683326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease.
    Fiocchi C; Hilfiker ML; Youngman KR; Doerder NC; Finke JH
    Gastroenterology; 1984 Apr; 86(4):734-42. PubMed ID: 6607860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.
    Kusugami K; Youngman KR; West GA; Fiocchi C
    Gastroenterology; 1989 Jul; 97(1):1-9. PubMed ID: 2785943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphokines and the intestinal immune response. Role in inflammatory bowel disease.
    Fiocchi C
    Immunol Invest; 1989; 18(1-4):91-102. PubMed ID: 2499538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulatory function of human intestinal mucosa lymphoid cells: evidence for enhanced suppressor cell activity in inflammatory bowel disease.
    Fiocchi C; Youngman KR; Farmer RG
    Gut; 1983 Aug; 24(8):692-701. PubMed ID: 6223862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New mediators of immunity and inflammation in inflammatory bowel disease.
    Monteleone G; Fina D; Caruso R; Pallone F
    Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune system alterations in patients with inflammatory bowel disease during remission.
    Sventoraityte J; Zvirbliene A; Kiudelis G; Zalinkevicius R; Zvirbliene A; Praskevicius A; Kupcinskas L; Tamosiūnas V
    Medicina (Kaunas); 2008; 44(1):27-33. PubMed ID: 18277086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversion of intestinal flow decreases the numbers of interleukin 4 secreting and interferon gamma secreting T lymphocytes in small bowel mucosa.
    Schmit A; Van Gossum A; Carol M; Houben JJ; Mascart F
    Gut; 2000 Jan; 46(1):40-5. PubMed ID: 10601053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A soluble factor produced by lamina propria mononuclear cells is required for TNF-alpha enhancement of IFN-gamma production by T cells.
    Prehn JL; Landers CJ; Targan SR
    J Immunol; 1999 Oct; 163(8):4277-83. PubMed ID: 10510366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of intestinal immune reactivity by interleukin 2. Phenotypic and functional analysis of lymphokine-activated killer cells from human intestinal mucosa.
    Fiocchi C; Youngman KR; Yen-Lieberman B; Tubbs RR
    Dig Dis Sci; 1988 Oct; 33(10):1305-15. PubMed ID: 3139381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of interferon gamma in the pathogenesis of Crohn's disease.
    Sasaki T; Hiwatashi N; Yamazaki H; Noguchi M; Toyota T
    Gastroenterol Jpn; 1992 Feb; 27(1):29-36. PubMed ID: 1555746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers.
    Fais S; Capobianchi MR; Pallone F; Di Marco P; Boirivant M; Dianzani F; Torsoli A
    Gut; 1991 Apr; 32(4):403-7. PubMed ID: 1902808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha (IFN-alpha) production by human intestinal mononuclear cells. Response to virus in control subjects and in Crohn's disease.
    Capobianchi MR; Fais S; Mercuri F; Boirivant M; Dianzani F; Pallone F
    Gut; 1992 Jul; 33(7):897-901. PubMed ID: 1644329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased spontaneous secretion of rheumatoid factor by intestinal lamina propria mononuclear cells from Crohn's disease but not ulcerative colitis patients.
    MacDermott RP; Schreiber S; Nash GS; Koopman WJ
    Clin Exp Immunol; 1993 Apr; 92(1):152-7. PubMed ID: 8467559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases.
    Sarra M; Monteleone I; Stolfi C; Fantini MC; Sileri P; Sica G; Tersigni R; Macdonald TT; Pallone F; Monteleone G
    Inflamm Bowel Dis; 2010 Aug; 16(8):1332-9. PubMed ID: 20186935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity.
    West GA; Matsuura T; Levine AD; Klein JS; Fiocchi C
    Gastroenterology; 1996 Jun; 110(6):1683-95. PubMed ID: 8964392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.